To be eligible for a Wegovy prescription, patients must meet specific clinical criteria based on weight, Body Mass Index (BMI), and the presence of weight-related health conditions. It is not intended for casual or cosmetic weight loss but is a prescription medication for individuals with obesity or overweight accompanied by comorbidities. The core eligibility requirements, which must be assessed and confirmed by a healthcare professional, are detailed below.
Understanding the Core BMI and Weight Criteria
The primary gateway to Wegovy eligibility is a patient’s Body Mass Index. BMI is a screening tool calculated from a person’s height and weight. For Wegovy, there are two main BMI-based pathways to qualification.
Pathway 1: Obesity
Adults with a BMI of 30 kg/m² or higher are typically classified as having obesity. In this case, a BMI of 30 or above alone qualifies a patient for a Wegovy prescription, as it indicates a significant excess of body fat that can pose health risks.
Pathway 2: Overweight with a Comorbidity
Adults with a BMI of 27 kg/m² or higher are classified as overweight. To be eligible for Wegovy under this pathway, the patient must also have at least one weight-related medical condition. This requirement underscores that the medication is for managing health risks, not just a number on the scale.
The following table provides a clear visual of the BMI criteria and the necessary conditions for each pathway.
| Patient Category | Required BMI | Additional Requirement |
|---|---|---|
| Adults with Obesity | ≥ 30 kg/m² | None |
| Adults who are Overweight | ≥ 27 kg/m² | At least one weight-related comorbidity (e.g., high blood pressure, type 2 diabetes, high cholesterol) |
Defining Qualifying Weight-Related Comorbidities
If a patient qualifies under the “overweight” pathway (BMI ≥ 27), the presence of a comorbidity is essential. These are not minor health issues but significant conditions that are either caused or exacerbated by excess weight. The key qualifying conditions include:
Type 2 Diabetes: This is a chronic condition where the body doesn’t use insulin properly, leading to high blood sugar. Excess weight is a major risk factor for developing type 2 diabetes, and weight loss can significantly improve blood sugar control.
Hypertension (High Blood Pressure): The heart has to work harder to pump blood through the body when a person is carrying extra weight. This increased force can damage artery walls over time. Managing weight is a first-line strategy for controlling hypertension.
Dyslipidemia (High Cholesterol or Triglycerides): This refers to unhealthy levels of lipids (fats) in the blood, such as high LDL (“bad”) cholesterol or high triglycerides. These conditions are strongly linked to obesity and increase the risk of heart disease and stroke.
Obstructive Sleep Apnea: This is a serious sleep disorder where breathing repeatedly stops and starts during sleep, often due to excess weight around the neck. Weight loss can dramatically reduce the severity of sleep apnea.
Cardiovascular Disease: A history of heart attack, stroke, or peripheral artery disease also qualifies as a relevant comorbidity, as weight management is a critical part of secondary prevention.
The Crucial Role of the Healthcare Provider’s Assessment
Meeting the BMI and comorbidity criteria is only the first step. The final decision for a prescription rests entirely with a licensed healthcare provider. This assessment is multi-faceted and goes beyond simple numbers.
Comprehensive Health Evaluation: Your doctor will conduct a thorough medical history review and physical examination. They will confirm your BMI calculation, verify any comorbid conditions through tests (like blood pressure readings or blood tests for cholesterol and blood sugar), and assess your overall health status.
Review of Previous Weight Loss Efforts: Wegovy is indicated for use in addition to a reduced-calorie diet and increased physical activity. Your provider will likely discuss what structured weight-management efforts you have tried in the past. This helps determine if a pharmacological intervention is an appropriate next step.
Determining Contraindications: Perhaps the most critical part of the assessment is ensuring Wegovy is safe for you. Your doctor will screen for conditions that make taking Wegovy too risky. Key contraindications include:
- Personal or Family History of Medullary Thyroid Carcinoma (MTC): Wegovy and similar drugs have caused thyroid C-cell tumors in animal studies. It is not known if this risk applies to humans, but the medication is contraindicated in patients with a personal or family history of MTC.
- Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): This is a genetic syndrome that predisposes individuals to certain tumors, including MTC.
- Severe Gastrointestinal Disease: Wegovy commonly causes gastrointestinal side effects like nausea, vomiting, and diarrhea. It may not be suitable for individuals with pre-existing severe gastrointestinal diseases.
- Pregnancy and Breastfeeding: Wegovy is not recommended for use during pregnancy or while breastfeeding due to a lack of safety data.
- Pancreatitis: A history of pancreatitis may also be a reason for a provider to avoid prescribing Wegovy.
- Allergy: A known hypersensitivity to semaglutide or any of the injection’s components.
Discussion of Risks and Benefits: A responsible provider will have a detailed conversation with you about the potential benefits of weight loss versus the possible side effects and costs associated with the treatment. This shared decision-making process is vital.
Insurance Coverage and Affordability Considerations
Even if you are medically eligible, practical eligibility often depends on insurance coverage. Wegovy is an expensive medication, and navigating insurance can be complex.
Prior Authorization: Most insurance plans require a prior authorization before they will cover Wegovy. This is a process where your doctor must submit documentation proving you meet the plan’s specific criteria, which often mirror the clinical guidelines (e.g., BMI ≥ 30, or BMI ≥ 27 with a comorbidity, plus proof of participation in a supervised weight management program).
Step Therapy: Some insurance plans implement “step therapy,” meaning they may require you to try and fail on other, often cheaper, weight-loss medications before they will approve coverage for Wegovy.
Variability in Coverage: Coverage for weight-loss medications varies dramatically between insurance providers and specific plans. Some employer-sponsored plans explicitly exclude coverage for anti-obesity medications. It is essential to contact your insurance provider directly to understand your plan’s formulary and coverage criteria. For those without coverage, patient assistance programs or savings cards from the manufacturer may help reduce the cost. If you are looking for a pharmacy that specializes in navigating these complexities for medications like wegovy, it can be beneficial to seek out dedicated compounding or specialized medical suppliers.
Commitment to Lifestyle Changes: A Non-Negotiable Component
Eligibility isn’t just a one-time checkmark at the doctor’s office. Successful and sustained weight loss with Wegovy requires an ongoing commitment to a healthier lifestyle. The medication is designed to work in conjunction with, not as a replacement for, diet and exercise.
Dietary Modifications: Wegovy works by mimicking a hormone that reduces appetite and slows stomach emptying. To be effective, patients need to adopt a reduced-calorie, nutritious diet. Overeating while on the medication can worsen gastrointestinal side effects.
Increased Physical Activity: Regular exercise is crucial for preserving muscle mass during weight loss, improving cardiovascular health, and boosting metabolism. A target of 150 minutes of moderate-intensity exercise per week is a common recommendation.
Behavioral Support: Addressing the psychological aspects of eating, such as emotional eating or habitual patterns, significantly improves long-term outcomes. Many comprehensive weight-management programs include behavioral therapy or counseling.
The journey to obtaining a Wegovy prescription is a structured process designed to ensure the medication is used safely and effectively by those who stand to benefit most. It begins with meeting specific, evidence-based medical criteria and culminates in a collaborative partnership with a healthcare provider to manage the treatment within the context of a holistic health plan.